About the Chamber



Date ArticleType
2/16/2016 Member News
Blood Bank of Delmarva Ships First Pathogen Reduced Platelet

Newark, DE  (February 16, 2016) – Almost one year to the day that Blood Bank of Delmarva (BBD) signed an agreement with Cerus Corporation for their INTERCEPT Blood System for platelets and plasma, the first product from this remarkable system has been shipped and transfused.  BBD was the first blood center in the United States to sign an agreement with Cerus for the INTERCEPT product.

With the first shipment also comes another first as the Department of Veterans Affairs Medical Center in Wilmington becomes the first medical facility in Delaware to transfuse this product.  The INTERCEPT Blood System reduces the risk of transfusion-transmitted infections such as Hepatitis B and C, HIV, West Nile Virus and malaria that could be present in donated blood.  INTERCEPT blocks the replication of pathogens such as viruses, bacteria and parasites, making them inactive.

“The implementation of the INTERCEPT system aligns with our mission of providing safe, effective blood products that best serve our hospital and patient community,” said BBD President and CEO Roy Roper.  “We are excited that our local VA Hospital was the first to adopt this new technology.  We expect many of our hospital partners on the Delmarva to follow their lead very soon.”

Blood Bank of Delmarva currently provides blood transfusion products and services to hospitals and patients in the Delmarva region.  BBD supplies approximately 7,000 platelet and 14,000 plasma units each year.

“This was indeed a team success” said Edyta Ryjewski, MT (ASCP) the Medical Center’s Blood Bank Lead Technologist.  “This came to fruition because of the extraordinary support from Blood Bank of Delmarva and the Cerus Corporation.”

Dr. Julie A. Horst, director of the medical center’s clinical laboratory added, “This is truly a remarkable step forward in the science of transfusion medicine which we are proud to be a part of. The INTERCEPT blood system greatly improves the safety of platelet and plasma transfusions we provide Veterans.”

About Blood Bank of Delmarva

The Blood Bank of Delmarva (BBD) is a not-for-profit 501(c) (3) community service organization which provides blood transfusion products and services for hospitals within the Delmarva region which includes Delaware as well as Maryland. BBD supplies approximately 75,000 red cell, 7,000 platelet, and 14,000 plasma units per year. For over 60 years, Blood Bank of Delmarva has ensured a safe and continuous supply of blood to meet the needs of over 20,000 patients annually. In addition to blood provisioning, BBD operates a full service regional laboratory providing donor testing and patient reference laboratory services for other blood collection centers and hospitals. BBD is FDA licensed, a member of America's Blood Centers, and accredited by AABB.

For more information about the Blood Bank or to schedule an appointment, visit www.DelmarvaBlood.org or call 1-888-8-BLOOD-8.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Press Contact: Michael Waite, (302)-737-8405 Ext. 732, mwaite@bbd.org